Market Overview:
The global biopharmaceutical third party logistics (3PL) market exhibited moderate growth during 2015-2020. Biopharmaceutical third-party logistics (3PL) refer to the services outsourced by pharmaceutical companies through third-party organizations. It involves receiving small molecule drugs, vaccines, biologics and other medical products into the warehouse, fulfilling orders and handling inventory of the goods through a warehouse management system. 3PL assists pharma and medical institutions in maintaining the logistics for delivering medical therapies, reducing medicine prices by minimizing wasteful overhead expenses, ensuring uninterrupted product supply, improving transportation services and enhancing the overall efficiencies of the organization.
Significant growth in the pharmaceutical industries is one of the key factors creating a positive outlook for the market. Furthermore, the emerging trend of outsourcing logistics by various medical organizations to optimize their distribution network is providing a thrust to the market growth. As the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for 3PL logistics to minimize drug supply disruptions and prioritize the availability of critical care drugs. Various technological advancements, such as the launch of warehouse robotics, mobile cloud computing, real-time monitoring and data mining solutions, are acting as other growth-inducing factors. These technologies aid in automating logistics-related processes and minimizing operation complexities, human errors and damages caused to the products in transit. In line with this, Near Field Communication (NFC) and Internet of Thing (IoT)-based cold chain monitoring products are also being used to manage temperature-sensitive pharmaceutical products and get real-time updates and alerts regarding the shipments. Looking forward, IMARC Group expects the global biopharmaceutical third party logistics (3PL) market to grow at a CAGR of around 7% during the forecast period (2021-2026).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biopharmaceutical third party logistics (3PL) market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, supply chain and service type.
Breakup by Supply Chain:
- Cold Chain
- Non-Cold Chain
Breakup by Service Type:
- Transportation
- Air Freight
- Sea Freight
- Overland
- Warehousing and Storage
- Others
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agility Logistics, AmerisourceBergen Corporation, DB Schenker (Deutsche Bahn), DHL International GmbH (Deutsche Post), FedEx Corporation, Kerry Logistics Network Limited, Kuehne + Nagel International AG, McKesson Corporation, SF Express Co. Ltd. and United Parcel Service of America Inc.
Key Questions Answered in This Report:
- How has the global biopharmaceutical third party logistics (3PL) market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global biopharmaceutical third party logistics (3PL) market?
- What are the key regional markets?
- What is the breakup of the market based on the supply chain?
- What is the breakup of the market based on the service type?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global biopharmaceutical third party logistics (3PL) market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biopharmaceutical Third Party Logistics (3PL) Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Supply Chain
6.1 Cold Chain
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Non-Cold Chain
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Service Type
7.1 Transportation
7.1.1 Market Trends
7.1.2 Key Types
7.1.2.1 Air Freight
7.1.2.2 Sea Freight
7.1.2.3 Overland
7.1.3 Market Forecast
7.2 Warehousing and Storage
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Agility Logistics
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.2 AmerisourceBergen Corporation
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 DB Schenker (Deutsche Bahn)
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.4 DHL International GmbH (Deutsche Post)
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.5 Fedex Corporation
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Kerry Logistics Network Limited
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 Kuehne + Nagel International AG
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.8 McKesson Corporation
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 SF Express Co. Ltd.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.10 United Parcel Service of America Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Biopharmaceutical Third Party Logistics Market: Major Drivers and Challenges
Figure 2: Global: Biopharmaceutical Third Party Logistics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Biopharmaceutical Third Party Logistics Market: Breakup by Supply Chain (in %), 2020
Figure 5: Global: Biopharmaceutical Third Party Logistics Market: Breakup by Service Type (in %), 2020
Figure 6: Global: Biopharmaceutical Third Party Logistics Market: Breakup by Region (in %), 2020
Figure 7: Global: Biopharmaceutical Third Party Logistics (Cold Chain) Market: Sales Value (in Million US$), 2015 & 2020
Figure 8: Global: Biopharmaceutical Third Party Logistics (Cold Chain) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 9: Global: Biopharmaceutical Third Party Logistics (Non-Cold Chain) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Biopharmaceutical Third Party Logistics (Non-Cold Chain) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Biopharmaceutical Third Party Logistics (Transportation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Biopharmaceutical Third Party Logistics (Transportation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Biopharmaceutical Third Party Logistics (Warehousing and Storage) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Biopharmaceutical Third Party Logistics (Warehousing and Storage) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Biopharmaceutical Third Party Logistics (Other Service Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Biopharmaceutical Third Party Logistics (Other Service Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: North America: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: North America: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: United States: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: United States: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Canada: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Canada: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Asia-Pacific: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Asia-Pacific: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: China: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: China: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Japan: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Japan: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: India: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: India: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: South Korea: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: South Korea: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Australia: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Australia: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Indonesia: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Indonesia: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Others: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Others: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Europe: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Europe: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Germany: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Germany: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: France: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: France: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: United Kingdom: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: United Kingdom: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Italy: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Italy: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Spain: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Spain: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Russia: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Russia: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Others: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Others: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Latin America: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Latin America: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: Brazil: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: Brazil: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Mexico: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Mexico: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Others: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Others: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Middle East and Africa: Biopharmaceutical Third Party Logistics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Middle East and Africa: Biopharmaceutical Third Party Logistics Market: Breakup by Country (in %), 2020
Figure 65: Middle East and Africa: Biopharmaceutical Third Party Logistics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Global: Biopharmaceutical Third Party Logistics Industry: SWOT Analysis
Figure 67: Global: Biopharmaceutical Third Party Logistics Industry: Value Chain Analysis
Figure 68: Global: Biopharmaceutical Third Party Logistics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Biopharmaceutical Third Party Logistics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Biopharmaceutical Third Party Logistics Market Forecast: Breakup by Supply Chain (in Million US$), 2021-2026
Table 3: Global: Biopharmaceutical Third Party Logistics Market Forecast: Breakup by Service Type (in Million US$), 2021-2026
Table 4: Global: Biopharmaceutical Third Party Logistics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 5: Global: Biopharmaceutical Third Party Logistics Market: Competitive Structure
Table 6: Global: Biopharmaceutical Third Party Logistics Market: Key Players